Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

U.S. reports its first human case of H5 bird flu

Published 04/29/2022, 12:51 AM
Updated 04/29/2022, 01:40 AM

(Reuters) - The first known human case of H5 bird flu in the United States has appeared in a person in Colorado, the Centers for Disease Control and Prevention (CDC) said on Thursday.

The person tested positive for avian influenza A(H5) virus and was involved in the culling of poultry presumed to have had H5N1 bird flu, the CDC said in a statement.

"This case does not change the human risk assessment for the general public, which CDC considers to be low," the agency added.

The patient reported fatigue for a few days as the only symptom and has since recovered, the CDC said, adding that the person was being isolated and treated with the influenza antiviral drug oseltamivir.

H5N1 viruses have been found in U.S. commercial and backyard birds in 29 states and in wild birds in 34 states since the CDC started monitoring for illness among people exposed to the viruses in late 2021.

"CDC has tracked the health of more than 2,500 people with exposures to H5N1 virus-infected birds and this is the only case that has been found to date. Other people involved in the culling operation in Colorado have tested negative for H5 virus infection, but they are being retested out of an abundance of caution," the CDC said.

Globally, this is the second human case associated with this specific group of H5 viruses, which are currently predominant, the CDC said. The first was reported in Britain in December 2021.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.